Subsidiary of Guangxi Wuzhou Zhongheng Group (600252.SH), Wuzhou Pharmaceutical, plans to be selected for centralized volume procurement by the national alliance for traditional Chinese medicine.

Guangxi Wuzhou Zhongheng Group (600252.SH) announced that its controlling subsidiary, Guangxi Wuzhou Pharmaceutical Co., Ltd. (referred to as "Wuzhou Pharmaceutical"), participated in the national centralized procurement of Chinese patent medicines alliance. Recently, according to the public notice of the National Office of Chinese Patent Medicines United Procurement, Wuzhou Pharmaceutical's injection medication Thrombolytic (freeze-dried) was selected as a non-quotation representative product in the national centralized procurement of Chinese patent medicines alliance. The selected product is Thrombolytic (freeze-dried) for injection use.